KATHRYN DUCLOS: Open Payments
NPI 1306016134 · AMHERST, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 24 payments from 8 companies in 2025. Trend: 2023 $285 · 2024 $668 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $336 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
Products named: UBRELVY, QULIPTA, VRAYLAR, Auvelity, CAPLYTA, M-M-R II, SKYRIZI, NURTEC ODT.
Industry payments across NH — which companies pay providers there.
